Understanding Methotrexate Pharmacokinetics and Patient Monitoring

This chapter explores the pharmacokinetics of methotrexate, emphasizing the half-life of its intracellular polyglutamates following treatment cessation. The discussion highlights the variability in patient responses, the need for monitoring potential toxicity, and upcoming topics on demard and biologic therapies.